Table of Contents
Beijing responded on Tuesday to the World Health Organization’s (WHO) plea for more information on the origins of Covid-19, asserting that it had shared data “without holding anything back.” This comes after the WHO issued a statement on Monday urging China to provide more transparency regarding the disease’s origins, stressing that it was both a “moral and scientific imperative.”
Covid-19, which first emerged in Wuhan, China, in December 2019, has caused global devastation, resulting in millions of deaths, economic disruptions, and overwhelmed healthcare systems. The virus’s origins continue to be a topic of international debate, with experts urging for more detailed investigation.
China’s Stance on Transparency and Global Contribution
In a press briefing on Tuesday, Chinese Foreign Ministry spokeswoman Mao Ning reiterated the country’s position, emphasizing China’s early cooperation in sharing crucial data about the virus. According to Mao, China provided the World Health Organization (WHO) and the international community with vital information, including viral gene sequences, as soon as the virus emerged.
“Five years ago, China immediately shared epidemic information and viral gene sequences with the WHO and the international community,” said Mao. “Without holding anything back, we shared our prevention, control, and treatment experience.” Mao also asserted that China had made significant contributions to global origin tracing research.
However, despite these claims, the WHO has repeatedly criticized China for not being fully transparent and cooperative throughout the pandemic. One of the most notable criticisms came during an investigation into the origins of the virus, conducted by a joint team of WHO experts and Chinese authorities in early 2021. The report from this investigation supported the hypothesis that the virus was transmitted from bats to humans, possibly through an intermediary animal at a Wuhan market.
Since that investigation, no new teams have been allowed back into China, and the WHO has continued to call for access to more data and further collaboration. As a result, tensions between China and the global health body persist, with the WHO urging for transparency in order to better understand the origins of the virus and prevent future pandemics.
Global Scope of Covid-19’s Origins
In her response to the WHO’s latest request, Mao stated that “more and more clues” suggested that the origins of Covid-19 were not confined to China alone, but had a “global scope.” She reiterated that China remained “willing to continue working with various parties to promote global scientific origin tracing” and expressed a commitment to preventing future pandemics.
Despite China’s insistence on its cooperation, many international experts and health officials remain unsatisfied with the information shared so far. The ongoing lack of access to data continues to hinder efforts to definitively trace the virus’s origins, and the issue remains one of the most contentious aspects of the global pandemic response.
WHO Calls for Preparedness in Case of Future Pandemics
The WHO’s Director-General, Tedros Adhanom Ghebreyesus, weighed in on the broader issue of global pandemic preparedness during a statement this month. He noted that the world continues to face significant vulnerabilities in the face of future pandemics. Despite some progress in strengthening global health systems, Tedros warned that many of the weaknesses that allowed Covid-19 to spread would still be present if a new pandemic were to emerge.
“The world would still face some of the same weaknesses and vulnerabilities that gave Covid-19 a foothold five years ago,” Tedros stated. “But the world has also learnt many of the painful lessons the pandemic taught us, and has taken significant steps to strengthen its defences against future epidemics and pandemics.”
In response to the devastation caused by Covid-19, countries began negotiating a global treaty on pandemic preparedness, response, and prevention. This treaty, being negotiated among the WHO’s 194 member states, aims to create a more coordinated global response to future health crises. While there is general agreement on the treaty’s key principles, negotiations are still ongoing, particularly on practical issues such as the speed at which emerging pathogens should be shared and how countries can access benefits like vaccines during pandemics.
One of the main points of contention in the negotiations is the tension between wealthy Western nations with significant pharmaceutical industries and poorer countries that fear being sidelined when it comes to future pandemic response. Despite this, negotiators hope to finalize the treaty by May 2025.
